Company Quick10K Filing
VNUE
10-K 2019-12-31 Filed 2020-05-19
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-14
10-Q 2016-09-30 Filed 2016-12-16
10-K 2016-06-30 Filed 2016-12-15
10-Q 2016-03-31 Filed 2016-12-15
10-K 2015-12-31 Filed 2016-12-15
10-Q 2015-09-30 Filed 2016-01-13
10-Q 2015-06-30 Filed 2015-12-08
10-Q 2015-02-28 Filed 2015-04-16
10-Q 2014-11-30 Filed 2015-01-20
10-Q 2014-08-31 Filed 2014-10-15
10-K 2014-05-31 Filed 2014-09-15
10-Q 2014-02-28 Filed 2014-04-17
10-Q 2013-11-30 Filed 2014-01-17
10-Q 2013-08-31 Filed 2013-10-15
10-K 2013-05-31 Filed 2013-09-16
10-Q 2013-02-28 Filed 2013-04-15
10-Q 2012-11-30 Filed 2013-01-14
10-Q 2012-08-31 Filed 2012-10-15
10-K 2012-05-31 Filed 2012-09-13
10-Q 2012-02-29 Filed 2012-04-17
10-Q 2011-11-30 Filed 2012-01-13
10-Q 2011-08-31 Filed 2011-09-19
10-K 2011-05-31 Filed 2011-08-29
10-Q 2011-02-28 Filed 2011-04-14
10-Q 2010-11-30 Filed 2011-01-14
10-Q 2010-08-31 Filed 2010-10-18
10-K 2010-05-31 Filed 2010-09-14
10-Q 2010-02-28 Filed 2010-04-21
10-Q 2009-11-30 Filed 2010-01-19
8-K 2020-05-14 Other Events
8-K 2020-03-30 Other Events
8-K 2019-07-02 Amend Bylaw, Shareholder Vote, Exhibits
8-K 2019-05-22
8-K 2018-09-04 Enter Agreement, Regulation FD
8-K 2018-07-19 Officers, Regulation FD, Exhibits
8-K 2018-06-08 Enter Agreement, Regulation FD

VNUE Financials

VNUE Metrics, Comps, Filings

Quarterly | Annual

Business

We are a music technology company, that offers a suite of products and services that monetize and monitor music for artists, labels, performing rights organizations, publishers, writers, radio stations, venues, restaurants, bars, and other stakeholders in music.

Our parent company, VNUE, Inc., was incorporated as a Nevada corporation on April 4, 2006. On May 29, 2015, VNUE, Inc. (formerly Tierra Grande Resources Inc.) ("we", "us" or "Our"), acquired VNUE, Inc., a company incorporated pursuant to the laws of the State of Washington ("VNUE Washington" or "VNUE"), resulting in VNUE becoming our wholly owned subsidiary and the holders of VNUE controlling our outstanding shares.

The acquisition of VNUE Washington was treated as a reverse acquisition, with VNUE Washington deemed the accounting acquirer of the company, and our publicly traded parent entity (formerly Tierra Grande Resources, Inc.) deemed the accounting acquiree under the acquisition method of accounting in accordance with Section 805-10-55 of the FASB Accounting Standards Codification.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Natcore Technology (NXT)
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
Amplitude Healthcare (AMHCU)
Galileo Acquisition (GLEO)
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
New You (NWYU)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
Electromedical Technologies (ELCQ)
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Anchiano Therapeutics (ANCN)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30

Balance Sheet ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash40919344721913983402313261333462812535802501877101673918532410
Accounts Receivable
Inventory
PP&E33233221110
Assets4272184992802191654730139628334628701468452550181412332314558534252262207168
Accounts Payable291011131231241076122896176281437510557392461523661698666
Long-Term Debt881,253
Liabilities331035436281441376122898112914547677871,4871,8702,0872,4133,0813,2172,8133,2394,3073,4544,1523,666
Stockholders' Equity394208145244191151441763515526-31741015-722-762-1,068-1,437-1,852-2,073-2,401-2,750-2,903-2,255-2,705-4,054-3,193-3,945-3,498
Income Statement ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0038155142465112
Cost of Revenue15487-1,089
Gross Profit-154-87-3531,126
R&D-4837671401277643254113240
SG&A17219241616736329921115-1361011331402,343183698155211280304186228318126707167
Tax00000000000000000000000000
Net Income-220-251-494-188-53-40-107-26-94-43-45-75-28-15-1,110-609-4,148-766-857-489-425-353-285-193-167-555374-1,674258
Cash Flow ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-216-148-257-79-5110-17-31-101-28-69-29-13-177-718-29-105-84-111-79-104-175-138-138-54-97
Cash Investing00-10-6000000-520
Cash Financing04023000-530140300700368778221153521007911016617017325